title: A new dawn in the treatment of dyslipidemia: cardiovascular risk reduction through emerging science and proven clinical results. Introduction.
authors.affiliation: Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, USA.
authors.forename: H Bryan
authors.initials: HB
authors.lastname: Brewer
mesh_terms: D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000209:etiology; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000628:therapy; D007249:Inflammation / Q000209:etiology / Q000628:therapy; D040242:Risk Reduction Behavior
chemical_list: D015415:Biomarkers